Fundamental dimension Equity attribute | AARDPeer $1.39▼-64.81% Cap $30.42MP/E -0.4x QuantScore43/100 | ASMBLeader $19.84▼-2.17% Cap $404.0MP/E 36.1x QuantScore58/100 | AVTXPeer $6.93▼-6.98% Cap $371.7MP/E -1.5x QuantScore38/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
23/100 |
39/100 |
23/100 |
Valuation Multiples, PEG & DCF upside | 75/100 | 37/100 | 33/100 |
Health Piotroski, Altman Z, leverage & liquidity | 60/100 | 75/100 | 64/100 |
Growth Revenue / earnings growth & margins | 0/100 | 75/100 | 20/100 |
Sentiment Analyst ratings, targets & revisions | 58/100 | 64/100 | 50/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -0.4x | 36.1x | -1.5x |
Forward P/E (next FY) | -0.5x | -32.6x | -2.4x |
EV / EBITDA (TTM) | 0.6x | 5500.3x | -2.9x |
Price / Sales | — | 5.4x | 6299.3x |
Price / Free Cash Flow | -0.4x | -10.5x | -5.6x |
PEG ratio | 0.01 | 0.05 | 0.01 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 1 / 9 | 2 / 9 | 2 / 9 |
Altman Z-Score | 3.44 (Safe) | 7.38 (Safe) | 4.13 (Safe) |
Total debt / equity | 0.01 | 0.01 | 0.00 |
Quick ratio | 12.6x | 14.0x | 19.3x |
Interest coverage | — | — | — |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | — | +153.5% | -86.6% |
Net income growth YoY | -179.7% | +84.8% | -122.8% |
Gross margin (TTM) | 0.0% | 77.7% | -16861.0% |
Operating margin (FY) | — | -16.8% | -123601.7% |
FCF margin (FY) | — | -56.9% | -87216.9% |
5. Trailing price performancePrice change over period |
1M return | -75.0% | -16.1% | -55.9% |
3M return | -78.0% | -22.3% | -62.4% |
6M return | -74.2% | -28.8% | -50.2% |
Year to date | -89.4% | -41.7% | -61.8% |
1Y return | -87.0% | -32.1% | -60.6% |
3Y return | -90.3% | +87.9% | -73.0% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $2.06 +48.1% upside | $-54.12 -372.8% premium | $0.9859 -85.8% premium |
Wall Street consensus target | $3.17 +128.1% · range $2.50–$4.00 | $51.67 +160.4% · range $50.00–$53.00 | $37.86 +446.3% · range $10.00–$60.00 |
Consensus stance | 44% Buy44% Hold11% Sell | 55% Buy45% Hold0% Sell | 60% Buy30% Hold10% Sell |